Clofarabine induces hypomethylation of DNA and expression of Cancer-Testis antigens

Leukemia Research

Volumn 33, Issue 12, 2009, Pages 1678-1683

  Zhang, Yana ^a   Shahriar, Masum ^a   Zhang, Jian ^a   Ahmed, Sharif Uddin ^a   Lim, Seah H ^a,b  

^a Landstuhl Regional Medical Center   (United States)

^b Blood and Marrow Transplant Program   (United States)

Author keywords

Clofarabine; CT antigen; DNA hypomethylation

Indexed keywords

CANCER TESTIS ANTIGEN; CLOFARABINE; DNA; PROTEIN SPAN XB; SPERM PROTEIN 17; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CPG ISLAND; DNA HYPOMETHYLATION; DNA METABOLISM; HUMAN; HUMAN CELL; LYMPHATIC SYSTEM TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADENINE NUCLEOTIDES; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; ARABINONUCLEOSIDES; CELL LINE, TUMOR; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS;

EID: 70249084864     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.04.005     Document Type: Article

References (18)

1. Reynolds S.R., Oratz R., Shapiro R.L., Hao P., Yun Z., Fotino M., et al. Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine. Int J Cancer 72 (1997) 972-976
2. Stockert E., Jager E., Chen Y.T., Scanlan M.J., Gout I., Karbach J., et al. A survey of the humoral immune responses to cancer patients to a panel of human tumor antigens. J Exp Med 187 (1998) 1349-1354
3. Traversari C. Tumor-antigens recognized by T lymphocytes. Minerva Biotechnol 11 (1999) 243-253
4. Lim S.H., Wang Z., Chiriva-Internati M., and Xue Y. Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Blood 97 (2001) 1508-1510
5. Wang Z., Zhang Y., Liu H.C., Chiriva-Internati M., and Lim S.H. Gene expression and immunologic consequence of SPAN-X in myeloma and other hematologic malignancies. Blood 101 (2003) 955-960
6. Wang Z., Zhang Y., Ramsahoye B., Bowen D., and Lim S.H. Sp17 gene expression in tumor cells is regulated by promoter methylation. Brit J Cancer 91 (2004) 1597-1603
7. Wang Z., Zhang J., Zhang Y., and Lim S.H. SPAN-Xb expression in myeloma cells is dependent on promoter hypomethylation and can be upregulated pharmacologically. Int J Cancer 118 (2006) 1436-1444
8. Kantarjian H., Gandhi V., Cortes J., Verstovsek S., Du M., Garcia-Manero G., et al. Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia. Blood 102 (2003) 2379-2386
9. Kantarjian H.M., Gandhi V., Kozuch P., Faderl S., Giles F., Cortes J., et al. Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers. J Clin Oncol 21 (2003) 1167-1173
10. Carson D.A., Wasson D.B., Esparza L.M., Carrera C.J., Kipps T.J., and Cottam H.B. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2′arabino-fluoro-2′-deoxyadenosine. Proc Natl Acad Sci USA 89 (1992) 970-2974
11. Parker W.B., Shaddix S.C., Chang C.H., White E.L., Rose L.M., Brockman R.W., et al. Effects of 2-chloro-9-(2-deoxy-2-fluoro-β-d-arabinofuransosyl adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymaerases by its 5′-triphosphate. Cancer Res 51 (1992) 2386-2394
12. Xie C., and Plunkett W. Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-β-d-arabinofuransosyl) adenine. Cancer Res 56 (1996) 3030-3037
13. Genini D., Adachi S., Chao Q., Rose D.W., Carrera C.J., Cottam H.B., et al. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria. Blood 96 (2000) 3537-3543
14. Grizzi F., Lim S.H., Chiriva-Internati M., Franceschini B., Wang Z., Lawrence D., et al. Sperm protein 17 is not expressed on normal leukocytes. Blood 99 (2002) 3479-3480
15. De Smet C., Lurouin C., Lethe B., Martelange V., and Boon T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 19 (1999) 7327-7335
16. Sigalotti L., Coral S., Nardi G., Spessotto A., Cortini E., Cattarossi I., et al. Promoter methylation controls the expression of MAGE2 3 and 4 genes in human cutaneous melanoma. J Immunother 25 (2002) 16-26
17. Yang A.S., Estecio M.R.H., Doshi K., Kondo Y., Tajara E.H., and Issa J.-P. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32 (2004) e38
18. Reichelova V., Liliemark J., and Albertioni F. Liquid chromatographic study of acid stability of 2-chloro-2′-arabino-fluoro-2′deoxyadenosine 2-chloro-2′-deoxyadenosine and related analogues. J Pharm Biomed Anal 13 (1995) 711-714